Benson Hill (BHIL): What Does the Company Do? — Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Summary
An agricultural biotech company that developed high-protein soybeans using its AI-based crop breeding platform CropOS. Bankruptcy and liquidation were completed in 2025, with core assets transferred to Confluence Genetics, an...
Subscribe🏢 What Is Benson Hill?
Benson Hill, Inc. was an agricultural biotech company founded in 2012 and headquartered in St. Louis, Missouri. It had been listed on NASDAQ under the ticker BHIL, but after going public through a SPAC merger in 2021, it failed to commercialize and filed for Chapter 11 bankruptcy protection in March 2025, which was subsequently converted to Chapter 7 liquidation in September of the same year. Its core technology was CropOS, an AI-based crop breeding platform that analyzed approximately 24,000 soybean candidate varieties and was used to develop high-protein, low-oligosaccharide soybeans (UHP-LO). In May 2025, all of its assets were sold to Confluence Genetics.
How does it make money?In its early stages, the company sold high-protein soybean raw materials directly to food and feed companies, but in 2024 it attempted to pivot to an asset-light licensing model. During the transition, it ran out of cash and filed for bankruptcy protection.
| Business Stage | Revenue (Year) | Description |
|---|---|---|
| Direct Raw Material Sales | $473.3 million (2023) | Direct supply of high-protein soybean raw materials to food and feed companies, focused on low-margin commodity trading |
| Licensing Model Pivot | $21.1 million (Q1 2024) | Shifted to seed genetics and trait licensing beginning in 2024; revenue dropped sharply but margins improved |
| CropOS Platform | - | AI and genomics-based breeding acceleration platform with approximately 350 patents, sold to Confluence Genetics |
| Current Status | Liquidation Completed | Chapter 7 liquidation in September 2025, total loss of shareholder value |
The CropOS platform and approximately 350 patents were transferred to Confluence Genetics (backed by S2G Investments and Expedition Ag Holdings), and commercialization of UHP-LO soybeans continues to be pursued.
📐 Market Cap and Company Size
Benson Hill is currently a liquidated company. Its market cap stands at {{MARKET_CAP}}, which is approximately {{SAMSUNG_RATIO}} of Samsung Electronics' market cap. The company had approximately {{EMPLOYEES}} employees (based on pre-asset-sale figures). At the time of its 2021 SPAC merger, the enterprise value was about $2 billion, but it collapsed to around $5 million just before bankruptcy.
📈 Benson Hill Outlook and Stock Price Movement
Stock value was completely wiped out following the NASDAQ trading halt in March 2025, the asset sale in May, and Chapter 7 liquidation in September. The stock is currently traded on OTC under the ticker BHILQ but is essentially a worthless residual liquidation share. The technology itself (CropOS) continues to advance through private company Confluence Genetics, with a target commercial soybean variety launch in 2029.
⚔️ Core Competitive Strengths and Risks
Benson Hill possessed innovative AI breeding technology but followed a typical failure path for ag-biotech companies: running out of cash before commercialization.
💪 Technical Strengths (Historical)
⚠️ Core Risks (Materialized)
🔄 Competitors and Related Stocks (Beneficiaries)
Competitors and similar technology companies include other NASDAQ-listed ag-biotech firms. Cybus (CBUS) is a comparable company pursuing a row crop trait licensing model, and Evogene (EVGN) develops AI genomics-based agricultural solutions. Large seed and trait companies such as Corteva (CTVA) also compete in similar markets.
Related stocks (beneficiaries) include plant-based protein and sustainable agriculture theme companies. Corteva (CTVA) may benefit from gaining specialty soybean market share following the BHIL asset sale, and grain processing majors such as Archer Daniels Midland (ADM) are also relevant.
Check the real-time stock prices and key indicators of related stocks in the table below.
Competitors| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
 CBUS | Cibus Inc | $1.59 | -0.3% | $121.1M | - | 8.2 | -225.93% | - |
 EVGN | Evogene Ltd | $0.48 | -4.3% | $7.6M | - | - | - | - |
| CTVA | Corteva Inc | $84.49 | -0.3% | $56.4B | 55.9 | 2.2 | 4.25% | 0.88% |
 RKDA | Arcadia Biosciences Inc | $0.45 | -5.6% | $1.1M | - | 1.6 | -430.93% | - |
 CMPS | Compass Pathways Plc ADR | $14.24 | -6.1% | $2.0B | - | 22.9 | -329.72% | - |
Related stocks (beneficiaries)| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| CTVA | Corteva Inc | $84.49 | -0.3% | $56.4B | 55.9 | 2.2 | 4.25% | 0.88% |
| ADM | Archer Daniels Midland Co | $86.91 | +0.4% | $41.9B | 23.8 | 1.8 | 7.7% | 2.45% |
 BG | Bunge Global SA | $124.59 | +0.9% | $23.9B | 24.2 | 1.5 | 7.53% | 2.31% |
 FMC | FMC Corp | $12.08 | -1.7% | $1.5B | - | 0.9 | -89.27% | 2.95% |
| DE | Deere & Co | $677.94 | +0.1% | $182.8B | 37.7 | 6.5 | 18.33% | 0.97% |
✅ Investor Checkpoints
Benson Hill is currently a liquidated company, and BHILQ is a worthless OTC-traded residual liquidation share. New investment is not recommended.
| Checkpoint | Item to Verify | Current Status |
|---|---|---|
| ⚖️ Legal Status | Is the company operating normally? | ❌ Chapter 7 liquidation completed in September 2025 |
| 💰 Shareholder Value | Are there any distributions to existing shareholders? | ❌ No shareholder distributions, stock value fully erased |
| 🏛️ Listing Status | Can the stock be traded on NASDAQ? | ❌ Delisted from NASDAQ, traded only on OTC (BHILQ) |
| 🔬 Technology Continuity | Is the CropOS technology still being developed? | ✅ Continuing development at Confluence Genetics |
BHILQ is a residual liquidation share with no investment value. If you are interested in AI-based crop breeding technology, indirect investment through related listed companies is advisable.
In summary, Benson Hill was a company that possessed innovative AI agricultural technology but was liquidated in 2025 after running out of cash before commercialization; its current stock (BHILQ) is a worthless residual liquidation share.
Check real-time quotes and technical indicators for related agricultural biotech stocks at a glance on US Stock Today's real-time dashboard.
Subscribe
Today's 5 AI picks, all free